Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Efficacy and Safety of Repeated NT 201 (Botulinum Neurotoxin Type A Free from Complexing Proteins) Treatments for up to 89 Weeks in Upper Limb Post-Stroke Spasticity
Neural Repair/Rehabilitation
(-)
136
Authors/Disclosures
Petr Kanovsky, PhD Dr. Kanovsky has nothing to disclose.
Irena Pulte Irena Pulte has received personal compensation for serving as an employee of Merz Pharmaceuticals . Irena Pulte has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file
Susanne Grafe, MD (Merz Pharmaceuticals GmbH) No disclosure on file
No disclosure on file
No disclosure on file